title: High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation.
authors.affiliation: Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pennsylvania 15213, USA.
authors.forename: W
authors.initials: W
authors.lastname: Li
authors.forename: L
authors.initials: L
authors.lastname: Lu
authors.forename: Y
authors.initials: Y
authors.lastname: Li
authors.forename: F
authors.initials: F
authors.lastname: Fu
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: A W
authors.initials: AW
authors.lastname: Thomson
authors.forename: S
authors.initials: S
authors.lastname: Qian
mesh_terms: D000818:Animals; D016572:Cyclosporine / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D006084:Graft Rejection / Q000276:immunology* / Q000473:pathology / Q000517:prevention & control; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D007166:Immunosuppressive Agents / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D016753:Interleukin-10 / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008815:Mice, Inbred Strains; D009200:Myocardial Contraction; D013154:Spleen / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D016559:Tacrolimus / Q000037:antagonists & inhibitors / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016753:Interleukin-10; D016572:Cyclosporine; D016559:Tacrolimus